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Although it is clear that genetic predispositions play a role
in progressive glomerulosclerosis, identification of specific
genes is difficult because of natural genetic heterogeneity
among individuals. We have reported a differential
susceptibility to progressive glomerulosclerosis after
induction of experimental glomerulonephritis anti-Thy-1
nephritis in Lewis rat substrains. Glomerular lesions in
Lewis/Møllegard rats resolve spontaneously, whereas
Lewis/Maastricht (Lew/Maa) rats develop progressive
glomerulosclerosis. This predisposition for progressive
glomerulosclerosis is governed by unknown genes that
are expressed by renal cells. Here, differential gene
expression analysis using a rat complementary DNA micro
array revealed neuronal activity-regulated pentraxin (Narp)
as a candidate gene involved in the remodeling or
progression of damaged glomeruli. Glomerular Narp
mRNA expression was monitored during disease in both
Lewis sub strains. Immunohistochemistry revealed that Narp
protein is exclusively expressed in Lew/Maa glomeruli 7 and
14 days after induction of anti-Thy-1 nephritis. Double-
immunofluorescent staining showed that proliferating
mesangial cells and parietal epithelial cells (PECs) at sites of
adhesion to podocytes are partially Narp-positive, whereas
podocytes fail to express Narp. Immunohistochemistry in
nephritic Wistar, unilaterally nephrectomized Wistar and
Sprague–Dawley rats showed that Narp protein is present
only in strains that develop progressive glomerulosclerosis
but never in strains that show remodeling. We conclude that
Narp is a predictor for anti-Thy-1 nephritis-induced
glomerulosclerosis and its expression by PECs may be
involved in the progression to glomerulosclerosis.
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Glomerulosclerosis of the kidney is a component of many
renal diseases including membranous nephropathy, diabetic
nephropathy, immunoglobulin A nephropathy, and lupus
nephritis. However, not all patients with renal disease show
progression to end-stage renal disease. Thus renal patients
can be subdivided based on clinical parameters into
progressors and non-progressors.1 It is unclear why patients
with renal diseases become progressors or non-progressors.
Fioretto et al.2 reported that in patients with severe diabetic
nephropathy the glomerular lesions resolved completely
within 5–10 years after pancreas transplantation, thereby
clearly demonstrating a natural self-repair capacity of the
kidney.
The concept of genetic contributions underlying
progression to renal failure is generally accepted, but human
studies have been hampered by natural genetic heterogeneity
among individuals, a paucity of available tissue and several
ethical considerations. Because of the resulting lack of
predictive markers for induction of glomerulosclerosis,
patients cannot currently be given a prognosis for the
development of progressive renal insufficiency. These
problems may be circumvented by comparing animal
strains that are progressors with those that are not in animal
models of renal disease. We previously identified two Lewis
rat substrains with small genetic differences but with
considerable differences in susceptibility to progressive
glomerulosclerosis following anti-Thy-1 nephritis making
them an ideal tool for identification of genes involved in pro-
gression.3 A single injection of anti-Thy1.1 antibody (ER4)
results in a full-blown mesangioproliferative glomerulo-
nephritis in both Lewis substrains. Glomerular lesions in
Lewis/Møllegard (Lew/Moll) rats, as in most rat strains,
spontaneously resolve within 4 weeks after induction of anti-
Thy-1 nephritis. In contrast, Lewis/Maastricht (Lew/Maa)
rats develop progressive glomerulosclerosis. In addition, we
have shown that this genetic predisposition for progression is
governed by genes expressed by renal cells and not by bone
marrow-derived cells.4 In an attempt to identify genes
involved in either remodeling, or progression of damaged
glomeruli, we performed a differential gene expression
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analysis between the two Lewis substrains during anti-
Thy-1 nephritis with a rat complementary DNA (cDNA)
micro array. Among a number of known genes with a
differential glomerular gene expression between both Lewis
sub strains we identified neuronal activity-regulated pentrax-
in (Narp).
Narp belongs to the gene family of neuronal pentraxins.
Narp is unique among neuronal pentraxins in that it is
regulated as an immediate early gene5 and it is essential for
long-term synaptic plasticity and nervous system develop-
ment.6–8 In this study we report, for the first time, Narp
expression in kidney and identify it as a candidate gene
involved in progressive renal disease.
RESULTS
Differential gene expression analyses
Array analysis showed that Narp mRNA clone (GenBankTM/
EBI accession number AA924551) was upregulated in Lew/
Maa glomeruli compared to Lew/Moll 3 and 21 days after
induction of anti-Thy-1 nephritis (respectively log2 ratio
2.54170.1951 and 3.288).
Kinetics of the Narp mRNA response
Real-time polymerase chain reaction (Q-PCR) of Narp
mRNA expression during the course of anti-Thy-1 nephritis
(Figure 1) showed that Narp was downregulated in both
substrains at day 1 compared to controls. In Lew/Moll rats,
Narp mRNA levels remained low until day 14 and never rose
above control values. In contrast, Narp mRNA levels in Lew/
Maa rats rose above control values, becoming significantly
higher at day 14 with a 2.5-fold increase. After 21 days Narp
mRNA levels of both substrains were similar to control
values.
Kinetics of the Narp protein response
Immunohistochemical staining revealed that normal glomeruli
were negative for Narp protein (results not shown) as were
Lew/Moll renal tissue samples at all time points (Figure 2a).
Narp protein was abundant in glomeruli from Lew/Maa rats
at 7 and 14 days (Figure 2b and d), whereas it was not present
at other time points. Narp protein was seen only in glomeruli
with lesions, and not in glomeruli without histological
abnormalities. These lesions are characterized by hypercellu-
larity and expansion of extracellular matrix within the
glomerular tuft. A diffuse staining pattern of Narp was
observed throughout the lesion with a more intense staining
of single cells (Figure 2b and d). In particular, glomeruli with
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Figure 1 | Kinetics of the glomerular Narp mRNA response by
Q-PCR. Numbers indicate days after induction of anti-Thy-1
nephritis. Data have been normalized for the housekeeping gene
hypoxanthine-guanine phophoribosyltransferase. *Po0.05
compared with control (one-way analysis of variance with
Bonferroni’s post hoc test).
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Figure 2 | Representative photographs of renal tissue stained for
Narp protein. (a, c) Complete absence of Narp immunostaining on
a paraffin section of glomeruli of Lew/Moll kidneys at 7 days after
induction of anti-Thy-1 nephritis. (a) illustrates a low magnification
of c. (b, d) The staining was abundantly present in the glomeruli
of Lew/Maa kidneys 7 days after induction of anti-Thy-1 nephritis.
(b) illustrates a low magnification of (d). Glomerular lesions are
characterized by hypercellularity and expansion of extra cellular
matrix within the glomerular tuft. As illustrated in E segmental
intra- and extracapillary proliferation can result in adhesion of
the tuft to parietal epithelium (periodic acid-Shiff (Pas) staining,
Lew/Maa, day 14). (f) Narp protein was diffused present
throughout the lesion, whereas the staining was more intense
at the site of tuft adhesion to parietal epithelium. (a, b, Original
magnification  200) (c–f, Original magnification  400).
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tuft adhesions showed strongly Narp-positive cells at the site
of adhesion. Narp protein could also be detected in tubular
epithelium of both normal and nephritic kidneys, but its
tubular level of detection had no relation to disease.
Figure 3 illustrates the percentage of all damaged
glomeruli observed with Narp staining throughout the
course of anti-Thy-1 nephritis in both Lewis substrains.
Eighty-four and 91% of damaged Lew/Maa glomeruli
contained Narp protein at 7 and 14 days after disease
induction, respectively. As shown in Figure 4, 32710% of all
damaged glomeruli contained sites of adhesion and expressed
Narp after 7 days and this percentage increased to 66717%
after 14 days. In addition, the percentage of glomeruli
expressing Narp without adhesion decreased from 5276 to
3178% between day 7 and day 14 of disease. This important
finding indicates that more glomerular tuft adhesions to
parietal epithelium had developed in time in the Lew/Maa
‘progressor’ strain. Only a small percentage of glomeruli with
lesions did not contain Narp protein (1677% at day 7;
371% at day 14) and none of those glomeruli showed tuft
adhesion. Overall, Narp expression is correlated with
glomerular tuft adhesion to parietal epithelium.
Because the majority of all Narp positive injured
glomeruli in Lew/Maa rats at 7 days did not show tuft
adhesions serial kidney sections were examined to search for
tuft adhesions throughout these glomeruli. Tuft adhesions
were absent in most of those glomeruli. This indicates that
initially Narp is expressed in mesangial cells but when these
lesions expand and adhere to parietal epithelium, Narp
expression is seen in both mesangial cells and parietal
epithelial cells (PECs).
Identification of Narp-positive cells in glomeruli
As a smooth muscle cell actin -positive staining has been
previously attributed to proliferating mesangial cells9 and we
observed that a small subset of a smooth muscle cell actin-
positive mesangial cells co-expressed Narp protein (Figure
5a), we conclude that part of the Narp-positive cells in
hypercellular lesions are proliferating mesangial cells.
Figure 5b shows a Lew/Maa glomerulus at day 7 with
hypercellularity and adhesion of the glomerular tuft to
parietal epithelium. Double-label staining of Narp with
podocalyxin showed that Narp-positive cells at the site of
adhesion could be ruled out as podocytes After double
labeling of Narp protein with CD10, a marker for PECs,10
doubly positive cells were clearly detected at the adhesion site
(Figure 5c and d). Note that in rats CD10 is expressed on
PECs, whereas in humans CD10 is expressed on podocytes
and proximal tubules.11,12
Narp protein was neither detected in monocytes/macro-
phages using ED1, nor in apoptotic cells using antibodies
against active Caspase 3 (Figure 5e and f respectively).
Similar staining patterns were seen in tissue samples
taken 14 days after induction of anti-Thy-1 nephritis (data
not shown).
Correlation of Narp expression with the course of disease in
various rat strains after anti-Thy-1 nephritis
Narp expression after induction of anti-Thy-1 nephritis was
examined in Wistar, Sprague–Dawley (SD) and Wistar
unilaterally nephrectomized (Unx) rats. Wistar rats develop
a more severe glomerulonephritis than Lew/Maa rats13,14 but
remodel completely within 3 weeks. Interestingly, they never
expressed Narp. This indicates that the severity of anti-Thy-1
nephritis does not determine whether remodeling or
progression will take place. Induction of anti-Thy-1 nephritis
in SD rats results in the development of a full-blown glomer-
ulonephritis as described previously.15 SD rats remodel, but it
takes more than 3 months (unpublished observation). In SD
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Figure 3 | Quantitative score of Narp-positive injured glomeruli in
Lew/Maa and Lew/Moll kidneys during the course of anti-Thy-1
nephritis. Complete absence of Narp protein in injured Lew/Moll
glomeruli during the course of anti-Thy-1 nephritis. Maximal
percentages of Narp expressing injured glomeruli were present in
Lew/Maa kidneys from day 7 (8473%) to day 14 (9175%), but
declined to control levels 21 days after induction of anti-Thy-1
nephritis.
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Figure 4 | Scoring of Lew/Maa glomeruli with or without Narp
protein expression in presence or absence of glomerular tuft
adhesion to parietal epithelium.
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rats the Narp protein staining pattern was similar to that seen
in Lew/Maa rats, but less intense.
Induction of anti-Thy-1 nephritis in Wistar Unx resulted
in progression to glomerulosclerosis, as judged by glomer-
ulosclerosis index at week 11 (data not shown). In contrast to
Wistar rats, Narp protein was expressed in glomerular lesions
at day 7 after induction of anti-Thy-1 nephritis in Wistar Unx
(Figure S1).
Figure 6 shows the continuum of Narp staining in five
strains showing rapid remodeling (Lew/Moll and Wistar), SD
showing slower remodeling and Lew/Maa and Wistar Unx
showing progression of disease.
DISCUSSION
In the present study we characterized the differential
kinetics of the mRNA and protein expression of Narp gene
during the course of anti-Thy-1 nephritis in two Lewis rat
substrains. We found glomerular Narp mRNA and protein
expression exclusively in rats with progressive glomerulo-
sclerosis. Narp was localized in glomerular proliferating
mesangial cells and in PECs at sites of adhesion of the
glomerular tuft to parietal epithelium. Whether the observed
tubular presence of Narp is due to tubular expression, or to
reabsorption of glomerular protein remains unclear. It should
be noted that tubular Narp expression was not correlated
with progression.
Narp was originally cloned by Tsui et al.5 as a novel
immediate-early gene and is a member of the pentraxin
family. The pentraxin family can be divided into two
subfamilies; the classic ‘short’ pentraxins, many of which
are acute phase proteins of the immune system, and the
‘long’ pentraxins among which are the neuronal pentraxins.6
Neuronal pentraxins, including Narp, are secreted, Ca2þ -
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Figure 5 | Representative illustrations of double-label
immunofluorescence stainings followed by confocal laser
scanning microscopy of Lew/Maa kidney sections collected
7 days after induction of anti-Thy-1 nephritis. (a) Proliferating
mesangial cells were present in Lew/Maa glomeruli specifically within
lesions. A small subset of a smooth muscle cell actin-positive
mesangial cells (red) co-expressed (yellow, arrow) with Narp protein
(green). (b) Double-label staining of Narp (green) with podocalyxin
(red) showed that podocytes failed to express or accumulate Narp
protein. (c) Co-expression (yellow, arrow) of PECs (CD10, red) with
Narp (green) at the adhesion site. (d) Magnification of co-expression
(yellow, arrow) in c. (e) Absence of co-expression of monocytes/
macrophages (ED1, red) and Narp (green). (f) Illustration of two serial
sections immunohistochemically stained with anti-cleaved caspase
3 (left section) and anti-Narp (right section). Apoptotic cells did not
co-localize with Narp-positive cells. (Original magnification  400).
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Figure 6 | Schematic illustration of glomerular Narp expression
in LewMoll, Wistar, SD, Wistar Unx and Lew/Maa rats during
anti-Thy-1 nephritis. Strains (Lew/Moll, Wistar) capable of
remodeling of glomerular injury within 3 weeks failed to express Narp
protein. Whereas SD slower remodel and Wistar Unx and Lew/Maa
rats develop progressive glomerulosclerosis and express Narp
protein. ‘’ absence of Narp protein, ‘þ ’ presence of Narp protein.
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dependent lectins that localize to excitatory synapses where
they bind to a-amino-3-hydroxy-5-methyl-4 isoxazole pro-
pionic acid (AMPA) type glutamate receptors. It is
hypothesized that they cluster or capture AMPA receptors
at synapses during the process of synaptogenesis and during
AMPA receptor trafficking that occurs in adult animals. Narp
is unique among neuronal pentraxins in that it is regulated as
an immediate early gene. Narp protein has only been
identified in brains of rat16 where it is essential for long-
term synaptic plasticity and nervous system development.6–8
Hsu and Perin17 identified the human NPTX2 gene which
shows 87% nucleotide homology with the rat Narp gene.
Narp is cofunctional with another neuronal pentraxin termed
NP1.18 Compared to Narp, NP1 shows modest ability to
induce excitatory synapse formation in neurons. However,
when the pentraxins are coexpressed, their synaptogenic
activity can be greater than either alone.19 Recently, a
significant downmodulation of the NP1 gene and the
neuronal pentraxin receptor gene during the development
of anti-Thy-1 nephritis in remodeling Wistar rats have been
shown.20,21
Narp has been shown to function only within the nervous
system. The present study is the first to report expression of
Narp in kidney and to identify this expression with
progression in anti-Thy-1 nephritis-induced glomerulo-
sclerosis.
Narp protein was expressed in proliferating mesangial cells
and PECs at day 7 and 14 after induction of anti-Thy-1
nephritis in Lew/Maa rats.
The gene expression profiles and Q-PCR measurements
were performed with RNA obtained from rat glomeruli
isolated by cortical sieving. This sieving technique separates
the glomeruli from extra glomerular tissue but also from
their Bowman’s capsule. However, because Bowman’s capsule
is not separated when glomerular tuft adhesions are present,
Figure 1 illustrates Narp mRNA levels produced by both
proliferating mesangial cells and PECs.
Wistar rats develop a more severe glomerulonephritis than
Lew/Maa rats13,14 as judged by microaneurysm formation,
influx of inflammatory cells and hyper proliferation, but
remodel completely within 3 weeks. Interestingly, they never
express Narp. This indicates that the severity of anti-Thy-1
nephritis does not determine whether remodeling or
progression will take place.
The development of progressive glomerulosclerosis fol-
lowing repeated injections of anti-Thy-1 or a single injection
after unilateral nephrectomy has been described pre-
viously.22,23 When we induced glomerulosclerosis in both
Unx and non-nephrectomized Wistar rats with anti-Thy-1.1
ER4 antibody we found expression of Narp protein in
glomeruli with tuft adhesions from Wistar rats with one
kidney and not in two-kidney Wistar rats. These findings
provide additional evidence that Narp is associated with
progressive glomerulosclerosis.
The pathological pathways leading to progressive glomer-
ulosclerosis are still poorly understood. Kriz24 proposes that,
as result of anti-Thy-1 nephritis, podocytes surrounding
glomerular lesions fail to maintain a complete cover of the
tuft resulting in tuft adhesions to Bowman’s capsule. These so
called ‘committed’ lesions cause misdirected filtration
towards the interstitium with the development of glomerulo-
sclerosis as an end result. In this concept progressive
glomerulosclerosis appears to be the result of continuing
injury to podocytes. However, our colocalization studies
revealed that Narp was not expressed by podocytes, but
mainly by PECs. Although this does not rule out initial
damage to podocytes that precedes Narp expression by PECs,
our results suggest a substantial role for PECs in the
development of glomerulosclerosis. Smeets et al. recently
also hypothesize a crucial role for PECs in the development
of FSGS in mice and human via podocyte–PEC bridging after
adherence of glomerular tuft to Bowman’s capsule.10,25,26 It
has also been reported that podocyte–PEC bridging is present
during the development of human immune crescentic
glomerulonephritis.27 Overall the data suggest that adherence
of glomerular tuft to Bowman’s capsule is probably a critical
step towards glomerulosclerosis.
In contrast to most rat strains the Lew/Maa strain is
not only susceptible to progressive glomerulosclerosis
following anti-Thy-1 nephritis, but also to other experi-
mental diseases. Lew/Maa rats are susceptible to streptococcal
cell wall-induced arthritis, a chronic erosive form of
polyarthritis, whereas F344 rats are resistant.28 The Lew/
Maa strain is susceptible to adjuvant-induced arthritis,
whereas the Lew/Moll strain is completely resistant to this
form of arthritis.29,30 Interestingly, nitric oxide generation by
inducible nitric oxide synthase is a key event in both the
induction of adjuvant arthritis31 and mesangial cell lysis in
the anti-Thy-1 nephritis model.32 Anti-Thy-1 nephritis-
induced tuft adhesions are characterized by hypercellularity
and mesangial extracellular matrix expansion within the
glomerular tuft. In these conditions the involved cells are
exposed to oxidative stress characterized by excessive and
uncontrolled production of reactive oxygen species. As a
result, Narp may act as an immediate early gene in response
to toxic concentrations of nitric oxide in the inflamed
glomerulus, resulting in oxidative stress responses in
glomerular epithelial cells.
In summary, in our search for genes involved in the
development of progressive glomerulosclerosis we have
identified Narp as a gene which is overexpressed in injured
glomeruli of rats that show progressive disease and absent in
strains which remodel and recover rapidly. Owing to the focal
aspect of glomerular lesions, tuft adhesions can be missed
during morphological examination of tissue sections.33
Because Narp is expressed throughout the lesion, detection
of Narp could be a more powerful prognostic marker for
progressive glomerulosclerosis than the tuft adhesion itself.
Whether Narp protein is not only associated with, but
also causally involved in the development of progressive
glomerulosclerosis requires further study. Regardless of
Narp’s role in disease, our data suggest that it may be useful
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as a marker of ‘likelihood to progress’ thereby providing a
much-needed prognostic marker.
MATERIALS AND METHODS
Animals
Female Lew/Maa rats were provided by Richard Frijns from the
University of Maastricht, Maastricht, The Netherlands. Female Lew/
Moll rats were obtained from M&B Breeding Center, Ry, Denmark.
Forty-nine animals of each substrain were divided in groups of seven
animals. Female inbred Wistar rats were obtained from the animal
facilities of the Department of Pathology, Leiden University Medical
Center, Leiden, The Netherlands. Female SD rats were obtained
from Sasco, Omaha, NE, USA. Animal care and experimentation
were in accordance with legislation on animal experiments as
determined by the Dutch Veterinary Inspection.
Induction of progressive and remodeling anti-Thy-1 nephritis
Anti-Thy-1 nephritis was induced in 10-week-old Lew/Maa and
Lew/Moll rats with injection of purified monoclonal anti-Thy-1.1
ER4 (2 mg/kg of body weight) in the tail vein.34 Animals were killed
6 h, 1 day and 3, 7, 14, and 21 days after disease induction. Ten-
week-old animals were used as controls. Kidneys were removed after
perfusion with phosphate-buffered saline (PBS). Part was fixed in
4% formalin and embedded in paraffin for histological examina-
tions. Remaining kidney samples were used for RNA analyses. The
complete (histo-) morphological course of anti-Thy-1 nephritis in
both substrains has been described previously.3,4 Anti-Thy-1
nephritis was also induced in two other remodeling rat strains,
Wistar and SD), in a similar way.13,15,35
Unilateral nephrectomy in Wistar rats before induction of anti-
Thy-1 nephritis with anti-Thy1.1 antibody Ox-7 and 1-22-3 has
been reported to lead to progressive glomerulosclerosis.22,23 To
induce progressive glomerulosclerosis female inbred Wistar rats
(n¼ 6), from the animal facilities of the Department of Pathology,
Leiden University Medical Center, Leiden, were Unx 1 week before
induction of anti-Thy-1 nephritis with ER4 antibody. Unx injected
with saline (n¼ 6), served as controls. Animals were killed at 1 week
or 11 weeks after injection of ER4 antibody or PBS and kidneys were
harvested after perfusion with PBS.
Glomerular RNA isolation and cDNA synthesis
Rat glomeruli were isolated using the differential sieving technique
as described previously.36 Isolated glomeruli of each animal group
were pooled. Subsequently RNA was isolated with TRIzol reagent
(Invitrogen Life Technologies, Carlsbad, CA, USA) according to the
instructions of the manufacturer. cDNA was prepared using AMV
reverse transcriptase (Roche, Mannheim, Germany) according to the
manufacturer’s instructions.
Differential gene expression analyses
Differential gene expression analyses were performed using a rat
cDNA micro array produced in our laboratories. We used a 28 000
rat cDNA library from I.M.A.G.E Consortium ((LLNL) cDNA
clones distributed by Invitrogen, Breda, The Netherlands). All cDNA
clones were amplified by standard PCR techniques. After amplifica-
tion fragment size and DNA quantity were checked with agarose gel
electrophoresis and if necessary clones were amplified again.
Subsequently all clones were concentrated and printed with the
417TM Arrayer (Affymetrix, Santa Clara, CA, USA) in duplicate on
aminosilane-coated micro array slides (Genetix, Hampshire, UK).
We examined the differential gene expression of all clones on 3 and
21 days after induction of anti-Thy-1 nephritis. Briefly, 10mg
glomerular RNA was labeled and hybridized on the cDNA micro
arrays using MICROMAXTM TSATM Labeling and Detection Kit
(Perkin Elmer Life Sciences, Boston, MA, USA) according to the
instructions of the manufacturer. Subsequently slides were scanned
with the GeneTAC LSIV scanner (Genomic Solutions, Ann Arbor,
MI, USA). Data were analyzed with GenePix Pro version 3.0
software (Molecular Devices Corporation, Union City, CA, USA). A
list of all genes upregulated and downregulated at 3 and 21 days of
disease genes between both substrains and the clone selection
criteria can be retrieved from a website www-onderzoek.lumc.nl/
pathology/kidney/progressive_glomerulosclerosis/.
Q-PCR
Q-PCR37 was performed in combination with the SYBR green core
kit (Eurogentec s.a., Seraing, Belgium) according to the instructions
of the manufacturer. Glomerular RNA (1 mg) was converted to
cDNA and subjected to Q-PCR, using Narp (GenBankTM/EBI
accession number S82649) gene-specific forward (50-CACAATGA
GACCTCGGCTCA-30) reverse (50-GCTCAGTCACCCTCTGCAGC
-30) primers and hypoxanthine-guanine phophoribosyltransferase38,
(GenBankTM/EBI accession number X62085) gene specific forward
(50-GGCTATAAGTTCTTTGCTGACCTG-30) and reverse (50-AACT
TTTATGTCCCCCGTTGA-30) primers. Gene-specific primers were
designed using Primer expressTM 1.5 program (Perkin Elmer Applied
Biosystems InC, Forster city, USA). To prevent amplification of
genomic DNA, primers were chosen spanning an exon-intron
junction. Q-PCR was performed using the iCycler iQ Q-PCR
Detection System and Icycler iQ version 3.1 software (Bio-Rad) and
software (Perkin Elmer Applied Biosystems). Amplification cycles
were 951C for 10 min, followed by 40 cycles at 951C for 15 s and at
601C for 60 s. Reaction kinetics were determined using a standard
curve. To correct for the amount of mRNA and the efficiency of
cDNA synthesis, the ratio of the levels of the investigated molecule
and the housekeeping gene hypoxanthine-guanine phophoribosyl-
transferase were used.39 All measurements were performed in
duplicate. Relative expression levels of Narp were calculated by
dividing the value of the gene by the mean of the household gene.
mRNA levels are shown as relative levels to the mean mRNA levels in
the controls, which were set to one.
Immunohistochemistry
Immunohistochemical staining was performed on kidneys fixed in
4% neutral-buffered formalin and embedded in paraffin. Four
micrometer sections were deparaffinized and pre-treated with Tris/
ethylenediaminetetraacetic acid 10/1 mM (pH 9.0) (10 min, 1001C)
for antigen retrieval. Slides were washed with PBS (3X) and treated
with 3% H2O2, 20% methanol/PBS for 4 min and washed with PBS
twice. Subsequently slides were treated with 1% Triton X-100 in PBS
(15 min) followed by a blocking treatment with 5% normal goat
serum, 0.2% Triton X-100/PBS (30 min). The pre-treated slides were
incubated with rabbit anti-rat Narp antibody for 24 h as described
previously.5 Primary antibodies were detected using the Dako
Chemate Envision HRP System (Dako, UK Ltd.) and diaminoben-
zidine as substrate. Stainings were enhanced with 0.5% CuSO4 and
slides were counterstained with hematoxilin. Of each individual
animal, one whole kidney section was microscopically examined.
The percentage of glomeruli with or without Narp protein
expression and whether Narp protein expression was present in
glomerular lesions with or without adhesion to partial epithelium
was determined. To examine Narp expression throughout glomeruli
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25-mm serial sections were cut. Glomerular Narp expression was
scored in a blinded fashion by two investigators.
Apoptotic cells sections were detected by stained with rabbit
anti-cleaved Caspase 3 antibodies (Cell Signaling Technology Inc.,
Beverly, USA) as described previously.40
Double-immunofluorescence stainings
Paraffin kidney sections 4 mm thick were pre-treated as described
above. Slides were incubated for 24 h with an antibody mixture
of rabbit anti-rat Narp antibody and one of the following anti-
bodies: ED1, a mouse monoclonal antibody which stains macro-
phages,41 mouse anti-a smooth muscle cell actin, which stains
proliferating mesangial cells (Sigma-Aldrich Chemie BV, Zwijn-
drecht, The Netherlands), mouse anti-rat podocalyxin, which stains
podocytes (kindly provided by Dr A Miettinen, Helsinki, Finland),42
mouse anti-human CD10, a marker for PECs in rodents
(Novocastra, Newcastle upon Tyne, UK). After washing three times
with PBS the slides were incubated with a mixture of two Alexa
Fluor conjugates according to the manufacturer’s instructions
(Invitrogen, The Netherlands). Images were acquired using Zeiss
LSM 510 Confocal Laser scanning microscope (Carl Zeiss BV,
Weesp, The Netherlands).
Statistics
Statistical significance was evaluated by one-way analysis of variance
analysis with a Bonferroni post hoc test. All data are expressed as
means7s.d. Statistical significance was defined as Po0.05.
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